Document is current
Any future updates will be listed below
-
Authors
Michel, Martin C.
Miller, Kurt
Schneider, Tim
Ude, Christian
Oelke, Matthias
-
Funding
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- License Information
-
More Information
Article History
Received: 4 December 2024
Accepted: 6 March 2025
First Online: 8 May 2025
Declarations
:
: The participation in the survey was voluntary and anonymous. There was no treatment as part of the survey, i.e., a non-interventional (observational) study. Based on the applicable laws and regulations in Germany, the applicable ethical committee (Ethical Committee of the chamber of physicians of Rhineland-Palatinate) informed us that an ethical vote was neither required nor proposed for this anonymous survey.
: MCM has received consultancy or speaker honoraria in urology from Apogepha, Astellas, Dr. Willmar Schwabe, GSK, MIP Pharma, Piere Fabre, and Sanofi-Aventis. KM and TS report no conflict of interest. CU has received honoraria from Bionorica and Dr. Willmar Schwabe. MO has received consultancy or speaker honoraria in urology from Apogepha, Astellas, Dr. Willmar Schwabe, GlaxoSmithKline, Pierre Fabre, SAJA Pharma and Sun Pharma.
